• SPX
  • $5,727.70
  • 0.49 %
  • $27.76
  • DJI
  • $42,120.75
  • 0.26 %
  • $109.15
  • N225
  • $38,635.62
  • 0.22 %
  • $83.56
  • FTSE
  • $8,291.85
  • 0.11 %
  • $9.33
  • IXIC
  • $18,022.54
  • 0.58 %
  • $104.07
Champions Oncology, Inc. (CSBR) Stock Price, News & Analysis

Champions Oncology, Inc. (CSBR) Stock Price, News & Analysis

Currency in USD Disclaimer

$4.63

$0.09

(1.98%)

Day's range
$4.5
Day's range
$4.63
50-day range
$3.6
Day's range
$5.45
  • Country: US
  • ISIN: US15870P3073
52 wk range
$3.6
Day's range
$7.13


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -1.83
  • Piotroski Score 4.00
  • Grade Buy
  • Symbol (CSBR)
  • Company Champions Oncology, Inc.
  • Price $4.63
  • Changes Percentage (1.98%)
  • Change $0.09
  • Day Low $4.50
  • Day High $4.63
  • Year High $7.13

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 12/10/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.72
  • Trailing P/E Ratio -6.39
  • Forward P/E Ratio -6.39
  • P/E Growth -6.39
  • Net Income $-7,276,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.